End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
10.73
CNY
|
+2.39%
|
|
+10.05%
|
-16.56%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8,461
|
8,589
|
7,301
|
6,235
|
3,725
|
6,626
|
Enterprise Value (EV)
1 |
8,037
|
8,286
|
6,821
|
6,039
|
4,381
|
7,589
|
P/E ratio
|
56.7
x
|
57
x
|
78.6
x
|
54.3
x
|
-40.2
x
|
-144
x
|
Yield
|
0.48%
|
0.36%
|
0.28%
|
0.37%
|
-
|
-
|
Capitalization / Revenue
|
11.4
x
|
9.94
x
|
9.4
x
|
6
x
|
4.18
x
|
8.31
x
|
EV / Revenue
|
10.9
x
|
9.59
x
|
8.78
x
|
5.81
x
|
4.92
x
|
9.52
x
|
EV / EBITDA
|
41.6
x
|
39.7
x
|
41.9
x
|
30.7
x
|
50.4
x
|
68.5
x
|
EV / FCF
|
-56.7
x
|
45.9
x
|
-128
x
|
-38
x
|
-10.3
x
|
-21.3
x
|
FCF Yield
|
-1.76%
|
2.18%
|
-0.78%
|
-2.63%
|
-9.72%
|
-4.7%
|
Price to Book
|
5.42
x
|
5.13
x
|
3.78
x
|
3.08
x
|
1.94
x
|
3.54
x
|
Nbr of stocks (in thousands)
|
515,253
|
515,253
|
515,253
|
515,260
|
515,261
|
515,261
|
Reference price
2 |
16.42
|
16.67
|
14.17
|
12.10
|
7.230
|
12.86
|
Announcement Date
|
4/7/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
739.1
|
863.9
|
776.5
|
1,039
|
891
|
797.1
|
EBITDA
1 |
193
|
208.7
|
162.7
|
196.5
|
87
|
110.9
|
EBIT
1 |
146.4
|
157.3
|
104.9
|
127.9
|
-15.22
|
-6.124
|
Operating Margin
|
19.8%
|
18.21%
|
13.51%
|
12.31%
|
-1.71%
|
-0.77%
|
Earnings before Tax (EBT)
1 |
160.3
|
173
|
103.8
|
129.8
|
-105.2
|
-47.63
|
Net income
1 |
146.6
|
150.6
|
92.87
|
114.8
|
-92.66
|
-45.88
|
Net margin
|
19.83%
|
17.43%
|
11.96%
|
11.06%
|
-10.4%
|
-5.76%
|
EPS
2 |
0.2895
|
0.2923
|
0.1802
|
0.2229
|
-0.1798
|
-0.0890
|
Free Cash Flow
1 |
-141.6
|
180.5
|
-53.24
|
-159
|
-425.6
|
-356.4
|
FCF margin
|
-19.16%
|
20.89%
|
-6.86%
|
-15.31%
|
-47.77%
|
-44.71%
|
FCF Conversion (EBITDA)
|
-
|
86.51%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
119.85%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0789
|
0.0600
|
0.0400
|
0.0450
|
-
|
-
|
Announcement Date
|
4/7/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
655
|
963
|
Net Cash position
1 |
424
|
303
|
480
|
196
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
7.533
x
|
8.686
x
|
Free Cash Flow
1 |
-142
|
181
|
-53.2
|
-159
|
-426
|
-356
|
ROE (net income / shareholders' equity)
|
9.92%
|
8.73%
|
4.82%
|
5.44%
|
-6.23%
|
-2.38%
|
ROA (Net income/ Total Assets)
|
5.78%
|
4.93%
|
2.56%
|
2.45%
|
-0.26%
|
-0.1%
|
Assets
1 |
2,535
|
3,052
|
3,627
|
4,693
|
35,246
|
44,983
|
Book Value Per Share
2 |
3.030
|
3.250
|
3.750
|
3.930
|
3.730
|
3.630
|
Cash Flow per Share
2 |
0.4100
|
0.3000
|
1.290
|
0.9300
|
0.7200
|
0.6100
|
Capex
1 |
187
|
219
|
204
|
379
|
499
|
388
|
Capex / Sales
|
25.32%
|
25.35%
|
26.21%
|
36.44%
|
56.05%
|
48.67%
|
Announcement Date
|
4/7/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -16.56% | 759M | | +14.70% | 64.83B | | -1.61% | 46.29B | | +14.58% | 40.05B | | +20.84% | 26.72B | | +1.16% | 17.45B | | -21.87% | 15.82B | | +1.11% | 15.02B | | -11.34% | 14.73B | | -20.82% | 13.34B |
Other Specialty Chemicals
|